Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BIOS

BioPlus Acquisition (BIOS)

BioPlus Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOS
DateTimeSourceHeadlineSymbolCompany
10/04/20237:30AMGlobeNewswire Inc.BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to LiquidateNASDAQ:BIOSBioPlus Acquisition Corporation
10/04/20237:30AMGlobeNewswire Inc.Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business CombinationNASDAQ:BIOSBioPlus Acquisition Corporation
08/16/20238:30AMGlobeNewswire Inc.Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient MonitoringNASDAQ:BIOSBioPlus Acquisition Corporation
07/17/20238:00AMGlobeNewswire Inc.Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of DirectorsNASDAQ:BIOSBioPlus Acquisition Corporation
06/14/20236:09AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
06/14/20236:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
06/13/20238:30AMGlobeNewswire Inc.Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth OrlandoNASDAQ:BIOSBioPlus Acquisition Corporation
05/30/20234:04PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
05/19/20234:50PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
05/19/20234:05PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
05/15/20234:29PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
05/15/20236:38AMEdgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:BIOSBioPlus Acquisition Corporation
05/12/20234:17PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOSBioPlus Acquisition Corporation
05/03/20238:47AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
05/03/20238:44AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
05/03/20238:30AMGlobeNewswire Inc.Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition CorporationNASDAQ:BIOSBioPlus Acquisition Corporation
04/27/20234:35PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BIOSBioPlus Acquisition Corporation
02/14/20233:39PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSBioPlus Acquisition Corporation
02/02/202310:10AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOSBioPlus Acquisition Corporation
11/03/20225:10PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
10/11/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
08/10/20224:33PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
05/12/20224:55PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
03/11/20224:05PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSBioPlus Acquisition Corporation
02/09/20222:14PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSBioPlus Acquisition Corporation
12/06/20218:00AMGlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSBioPlus Acquisition Corporation
12/02/20218:55PMGlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSBioPlus Acquisition Corporation
02/03/20208:30AMGlobeNewswire Inc.Option Care Health Completes Reverse Stock Split and Ticker Symbol ChangeNASDAQ:BIOSBioPlus Acquisition Corporation
12/26/20194:24PMGlobeNewswire Inc.RLH Corporation Appoints R. Carter Pate as ChairmanNASDAQ:BIOSBioPlus Acquisition Corporation
12/18/20199:22AMGlobeNewswire Inc.Option Care Health to Participate in the 38th Annual J.P. Morgan Healthcare ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOS